Des glycopolymères greffés et dibloc, amphiphiles et photosensibles, à base de poly(acrylate d'o-nitrobenzyle) (PNBA) hydrophobe et photoclivable et de dextrane hydrophile ont été préparés avec succès en utilisant notammennt une réaction d'Huisgen (Cycloaddition Azoture-Alcyne catalysée par le Cuivre (I) - CuAAC chimie click). Dans un premier temps, la polymérisation de l'acrylate d'o-nitrobenzyle a été contrôlée avec succès grâce aux développements récents de la polymérisation radicalaire vivante par transfert d'un seul électron (SET-LRP). Nous avons alors obtenu un PNBA fonctionnalisé à son extrémitié par un brome. Ce brome a ensuite été substitué par un groupe azido. En parallèle, le dextrane a été modifié pour y introduire plusieurs fonctions alcyne (dextrane alcyne) ou une seule sur son extrémité réductrice (dextrane α-alcyne). Nous avons ensuite fait réagir ces dérivés de dextrane avec le PNBA-N3 pour obtenir respectivement les glycopolymères greffés et dibloc. Tous les glycopolymères ont été caractérisés par chromatographie d'exclusion stérique (SEC), Résonnance Magnétique Nucléaire 1H, 13C, 2D DOSY 1H et par spectrométrie FT-IR. Dans un deuxième temps, nous avons optimisé les conditions pour obtenir des nanoparticules peu disperses à partir des précédents glycopolymères. Dans certains cas, des nanoparticules ont également été obtenues en utilisant le dextrane alcyne et le PNBA-N3 dans un procédé d'émulsion/évaporation de solvant organique. La stabilité de toutes les nanoparticules vis-à-vis de solutions aqueuses de diverses forces ioniques ou d'un tensioactif compétitif a été étudiée. Enfin, l'effet de la lumière sur ces nanoparticules photosensibles a été mis en évidence à l'aide de la lampe UV. Plus précisément, nous avons pu suivre la destruction des nanoparticules par spectroscopie de fluorescence et diffusion de lumière dynamique en encapsulant le Rouge du Nil (sonde fluorescente) au sein de ces particules / Photosensitive grafted and diblock amphiphilic glycopolymers based on hydrophobic photosensitive poly(o-nitrobenzyl acrylate) (PNBA) and hydrophilic dextran were successfully prepared via grafting onto techniques through a Huisgen-type Copper(I) catalyzed Azide-Alkyne Cycloaddition (CuAAC click chemistry). Firstly, recent developments in the single-electron transfer–living radical polymerization (SET–LRP) provided us an access to control the o-nitrobenzyl acrylate polymerization and we obtained PNBA with bromide end function. Then, this bromide end function was replaced by azido (N3) group. In a parallel way, we modified dextran by introducing several alkyne groups all long the polysaccharide chain (alkynated dextran) or only one group at the reducing end-chain (α-alkyne dextran). In the second step, alkynated dextran and α-alkyne dextran were reacted with PNBA-N3 by CuAAC to obtain grafted or diblock glycopolymers. All glycopolymers were characterized by Size Exclusion Chromatography, 1H, 13C, 2D DOSY 1H NMR and FT-IR spectroscopy. Secondly, conditions to formulate nanoparticles from the previous glycopolymers were optimized. In some case, we also carried out an emulsion/evaporation process using dextran alkynated and PNBA-N3 to produce nanoparticles. Then, stability of nanoparticles were studied over rang of ionic strengths as well as stability in presence of a competitive surfactant. Finally, the effect of light on these photosensitive nanoparticles was studied using UV-lamp. More precisely, we loaded these nanoparticules by Nile Red fluorescent dye and followed thier destruction by using fluorescence spectroscopy and Dynamic Light Scattering

<p>Megalin is an endocytotic receptor belonging to the low-density lipoprotein family. It has often been viewed only as merely a scavenger receptor of absorptive and secretory epithelia. Recent work has revealed that the megalin intracellular domain contains several motifs potentially binding proteins involved in signal transduction. </p><p>To find potential intracellular proteins binding to megalin, a yeast two-hybrid screening was initiated with the intracellular tail of megalin as the bait. A partial clone encoding the scaffolding protein postsynaptic protein 95 (PSD-95) was found to bind to megalin with its second PDZ-domain. Co-localization experiments in HEK-293 cells and kidney, placenta and parathyroid tissue confirmed this interaction. The PSD-95 related proteins PSD-93 and SAP102 were also confirmed to bind megalin with their PDZ2-domains, but the corresponding domain from SAP97 did not bind. Mutation analysis revealed that an amino acid residue change Ala to Thr was the cause of this.</p><p>Megalin has within the central nervous system (CNS) been shown to be expressed only in the ependymal cells and choroid plexus. Nothing has been known about megalin expression in the spinal cord. To study spatio-temporal expression of megalin in the spinal cord, extensive staining of prenatal and postnatal mouse spinal cord was undertaken. Megalin expression was found in the dorsal part of the embryonic spinal cord. Most of these cells also expressed vimentin, suggesting that megalin has a role in the normal development of astrocytes. In the postnatal mouse, megalin seems to be expressed in oligodendrocytes only in the spinal cord white matter, and co-incident with myelination. This suggests that megalin is involved in the formation and maintenance of myelin along long spinal pathways. Megalin staining was clearly seen in the nucleus of these cells, indicating that megalin works in a notch-like signalling pathway.</p><p>Uptake of retinol to the retina pigment epithelium (RPE) has long been thought to be a diffusion process. Staining for megalin in RPE revealed strong expression, and uptake experiments with 3H-retinol bound to retinol-binding protein and blocking with the LDL-receptor family specific antagonist receptor-associated protein (RAP) showed that megalin is a receptor for uptake of retinol to the RPE.</p>

Megalin is an endocytotic receptor belonging to the low-density lipoprotein family. It has often been viewed only as merely a scavenger receptor of absorptive and secretory epithelia. Recent work has revealed that the megalin intracellular domain contains several motifs potentially binding proteins involved in signal transduction. To find potential intracellular proteins binding to megalin, a yeast two-hybrid screening was initiated with the intracellular tail of megalin as the bait. A partial clone encoding the scaffolding protein postsynaptic protein 95 (PSD-95) was found to bind to megalin with its second PDZ-domain. Co-localization experiments in HEK-293 cells and kidney, placenta and parathyroid tissue confirmed this interaction. The PSD-95 related proteins PSD-93 and SAP102 were also confirmed to bind megalin with their PDZ2-domains, but the corresponding domain from SAP97 did not bind. Mutation analysis revealed that an amino acid residue change Ala to Thr was the cause of this. Megalin has within the central nervous system (CNS) been shown to be expressed only in the ependymal cells and choroid plexus. Nothing has been known about megalin expression in the spinal cord. To study spatio-temporal expression of megalin in the spinal cord, extensive staining of prenatal and postnatal mouse spinal cord was undertaken. Megalin expression was found in the dorsal part of the embryonic spinal cord. Most of these cells also expressed vimentin, suggesting that megalin has a role in the normal development of astrocytes. In the postnatal mouse, megalin seems to be expressed in oligodendrocytes only in the spinal cord white matter, and co-incident with myelination. This suggests that megalin is involved in the formation and maintenance of myelin along long spinal pathways. Megalin staining was clearly seen in the nucleus of these cells, indicating that megalin works in a notch-like signalling pathway. Uptake of retinol to the retina pigment epithelium (RPE) has long been thought to be a diffusion process. Staining for megalin in RPE revealed strong expression, and uptake experiments with 3H-retinol bound to retinol-binding protein and blocking with the LDL-receptor family specific antagonist receptor-associated protein (RAP) showed that megalin is a receptor for uptake of retinol to the RPE.

In the course of development organisms learn to associate their actions with the effects these actions have in the environment. Recent studies have shown that perceiving or anticipating action-effects automatically activates actions, which formerly have been experienced to cause these effects (Elsner &amp;amp; Hommel, 2001). Using subliminal priming paradigms and electrophysiological measures I investigated whether subliminally (i.e., not consciously perceivable) presented action-effects can automatically activate associated actions and if so, whether this response priming by action-effects can bias free-choice actions. Secondly I investigated whether action-effects with different emotional valences influence response selection differently. To address the first question three experiments were performed. Each experiment consisted of two experimental phases. The first phase, the acquisition-phase, was a learning phase were simple key-press actions were associated with simple visual stimuli (i.e., action-effects; diamond or square) that were contingent on the actions. Immediately after the acquisition-phase the test-phase followed, in which participants performed free-choice actions after the presentation of a Go-signal. In Experiments 2 and 3 a NoGo-signal indicating that responses had to be withheld could appear with the same likelihood as the Go-signal. Unknown to the participants, one of the former action-effects (diamond or square) was presented subliminally prior to each Go- and NoGo-signal to investigate the influence of unconscious action-effects on response selection. Taken together, the results of the test-phases provided strong evidence that even subliminally presented (i.e., unconscious) action-effects can automatically activate associated responses. The response priming by action-effects became evident in the lateralized readiness potential (LRP), an electrophysiological indicator of specific response activation processes. Under certain circumstanced this automatic response activation can bias free-choice actions although participants experienced the actions as freely chosen. In the test-phase of the first experiment more acquisition-phase-consistent than –inconsistent responses were chosen. If, for instance, a left key-press had been associated with a square during the acquisition-phase, the left key was chosen significantly more often after the subliminal presentation of a square in the test-phase. At least three factors seemed to influence which responses were chosen and executed: The strength of the priming effect, the complexity of the task (i.e., pure Go-blocks or intermixed Go/NoGo-blocks), and the elapsed time between the prime stimulus and the Go-signal. To address the second question simple key-press actions were linked to action-effects with different emotional valences (positive vs. negative pictures accompanied by high or low tones) during the acquisition-phase. In the subsequent test-phase, the effects-tones that had been associated with negative or positive pictures were presented and followed by a Go-signal, after which participants had to freely choose to press one of the two response keys. Results indicated that the anticipation of the emotional valence of an action-effect influenced free-choice action. Whereas the effect-tones induced a clear response bias (i.e., more acquisition-consistent than –inconsistent key-choices) if they had been associated with a positive emotional valence, this response bias was not reliable for action-effects associated with negative emotional features. In summary, the present results provide further proof for ideomotor theories of action control (James, 1890; Elsner &amp;amp; Hommel, 2001) which state that actions are automatically activated by anticipating their consequences.

F1651, les pili Pap et l’antigène CS31A associé aux antigènes de surface K88 sont tout trois des membres de la famille de type P des facteurs d’adhérence jouant un rôle prépondérant lors de l’établissement d’une maladie causée par des souches Escherichia coli pathogènes, en particulier des souches d’E. coli pathogènes extra-intestinales (ExPEC, Extra-intestinal pathogenic E. coli). Leur expression est sous le contrôle d’un mécanisme de régulation transcriptionnel dépendant de l’état de méthylation de l’ADN, résultant dans l’existence de deux populations définies, l’une exprimant l’adhésine (population ON) et l’autre ne l’exprimant pas (population OFF). Malgré de fortes identités de séquences, ces trois systèmes diffèrent l’un de l’autre, principalement par le pourcentage de cellules ON rencontrées. Ainsi, quand CS31A est systématiquement orienté vers un état considéré comme OFF, F1651 présente une phase ON particulièrement élevée et Pap montre deux états OFF et ON bien distincts, selon le phénotype de départ. La protéine régulatrice sensible à la leucine (Lrp, Leucine-responsive regulatory protein) joue un rôle essentiel dans la réversibilité de ce phénomène épigénétique et il est supposé que les différences de séquences au niveau de la région régulatrice modifient la localisation à ces sites de fixation de Lrp; ce qui résulte, en final, aux différences de phase existant entre CS31A, F1651 et Pap.À l’aide de divers techniques parmi lesquelles l’utilisation de gènes rapporteurs, mutagénèses dirigées et d’analyse des interactions ADN-protéines in vitro, nous montrons dans ce présent projet que la phase OFF prédominante chez CS31A est principalement due à une faible interaction de Lrp avec la région distale de l’opéron clp, et que la présence d’un homologue du régulateur local PapI joue un rôle également clef dans la production de CS31A. Dans le cas de F1651, nous montrons dans cette étude que le taux élevé de cellules en phase ON est dû à une altération dans le maintien de Lrp sur les sites répresseurs 1-3. Ceci est dû à la présence de deux nucléotides spécifiques, situé de part et d’autre du site répresseur 1, qui défavorisent la fixation de Lrp sur ce site précis. Tout comme dans le cas de CS31A, la formation d’un complexe, activateur ou répresseur de la phase ON, dépend également de l’action de du régulatuer local FooI, qui favorise alors le déplacement de Lrp des sites répresseurs 1-3 vers les sites activateurs 4-6. / F1651, the pyelonephritis-associated pili (Pap) and the K88-related surface antigen CS31A are three members of the type P family of adhesive factors that play a key role in the establishment of disease caused by Extra-intestinal Escherichia coli (ExPEC) strains. They are all under the control of methylation-dependent transcriptional regulation that defines the number of fimbriated (ON) and afimbriated (OFF) cells within a clonal population. Despite a high similarity in DNA sequence, these three adhesive systems nonetheless differ in the ratio of ON cells. While CS31A is always turned toward the OFF state, F1651 presents a particularly high level of ON cells and Pap shows two distinct OFF and ON states, depending on the starting phenotype. The leucine-responsive regulatory protein (Lrp) plays an essential role in the reversibility of this epigenetic switch and it is believed that the difference in nucleotides within the regulatory region of each operons could modify the binding of Lrp and, in turn, CS31A, Pap and F1651 phase variation. Using a variety of techniques including gene expression, site-directed mutagenesis, and in vitro protein–DNA interaction analysis, we demonstrate that the preferential OFF state observed in CS31A-positive cells is mainly due to a weak interaction of Lrp with the clp distal region and that the presence of a PapI homologue within the cell plays a key role in CS31A production. For F1651, we show in this study that the high level of ON cells found during F1651 phase variation is due to an altered stability of the DNA complex formed by Lrp at its repressor binding sites 1-3. Again, after each cell cycle, complex formation is modulated by the local regulator FooI (homologue to PapI) which promotes the transit of Lrp toward its activator binding sites 4-6. Furthermore, we identify two nucleotides (T490, G508) surrounding the Lrp-binding site 1 that are critical to maintaining a high OFF to ON switch rate during F1651 phase variation, as well switching Pap fimbriae toward the OFF state.

Φυσιολογικά επίπεδα της αγρίου τύπου απολιποπρωτεϊνης Ε (apoE) στο πλάσμα διαμεσολαβούν στην κάθαρση των αθηρογενετικών λιποπρωτεϊνών ενώ υψηλότερα επίπεδα από τα φυσιολογικά προκαλούν υπερτριγλυκεριδαιμία. Αυτή η ιδιότητα της αγρίου τύπου apoE μειώνει σημαντικά την θεραπευτική της αξία ως ένα πιθανό βιολογικό φάρμακο για την αντιμετώπιση της δυσλιπιδαιμίας. Πρόσφατα, έχει δημιουργηθεί και μελετηθεί μια μεταλλαγμένη μορφή της apoE, apoE4 [ L261A, W264A, F265A, L268A, V269A ] (apoE4mut1) με βελτιωμένες βιολογικές ιδιότητες. Συγκεκριμένα, αυτή η μεταλλαγμένη μορφή μπορεί να φέρει τα υψηλά επίπεδα χοληστερόλης σε φυσιολογικές τιμές χωρίς να προκαλέσει υπερτριγλυκεριδαιμία ακόμα και όταν υπερεκφράζεται. Στην παρούσα μελέτη, πραγματοποιήθηκε φαρμακοδυναμική και φαρμακοκινητική ανάλυση της apoE4mut1 σε πειραματόζωα. Με γονιδιακή μεταφορά μέσω ιού σε ποντίκια που είχαν έλλειψη στον LDL υποδοχέα (LDLr-/-) και σε ποντίκια που είχαν έλλειψη στην apoE (apoE-/-), δείχθηκε οτι η δράση της apoE4mut1 ( μείωση της χοληστερόλης ) εξαρτάται από την έκφραση ενός λειτουργικού κλασσικού LDL υποδοχέα. Εφάπαξ έγχυση της apoE4mut1 συνδεδεμένης με λιποσώματα σε apoE-/- ποντίκια που ήταν σε δίαιτα δυτικού τύπου για 6 εβδομάδες αποκάλυψε οτι η εξωγενώς συντιθέμενη apoE4mut1 διατηρεί άθικτη την ικανότητά της να κανονικοποιεί τα υψηλά επίπεδα χοληστερόλης αυτών των ποντικιών με μια μέγιστη φαρμακολογική απόκριση που παρατηρείται σε μόλις 10 ώρες μετά την έγχυση. Ενδιαφέρον παρουσίασε το γεγονός οτι τα επίπεδα χοληστερόλης του πλάσματος παρέμειναν σημαντικώς μειωμένα για τις επόμενες 24 ώρες μετά την έγχυση της apoE4mut1- λιποσώματα. Μετρήσεις συγκεντρώσεων της apoE έδειξαν οτι η apoE4mut1 στην μορφή των πρωτεολιποσωμάτων που χρησιμοποιήθηκαν σε αυτή τη μελέτη έχει χρόνο ημίσειας ζωής 15.8 h. Τα δεδομένα αυτά οδηγούν στο συμπέρασμα οτι η καθαρή apoE4mut1 μπορεί να αποτελέσει ένα νέο υποψήφιο φάρμακο για την άμεση αντιμετώπιση της υπερχοληστερολαιμίας σε άτομα που εκφράζουν έναν λειτουργικό LDL υποδοχέα. / Physiological levels of wild-type (wt) apolipoprotein E (apoE) in plasma mediate the clearance of cholesterol-rich atherogenic lipoprotein remnants while higher than normal plasma apoE concentrations fail to do so and trigger hypertriglyceridemia. This property of wt apoE reduces significantly its therapeutic value as a potential biological drug for dyslipidemia. Recently, we reported the generation of a recombinant apoE variant, apoE4 [L261A, W264A, F265A, L268A, V269A] (apoE4mut1) with improved biological functions. Specifically, this variant can normalize high plasma cholesterol levels without triggering hypertriglyceridemia, even at supraphysiological levels of expression. In the present study we performed pharmacodynamic and pharmacokinetic analysis of apoE4mut1 in experimental mice. Using adenovirus-mediated gene transfer in LDL receptor deficient (LDLr-/-) and apoE deficient (apoE-/-) mice, we show that the cholesterol lowering potential of apoE4mut1 is dependent on the expression of a functional classical LDLr. Bolus infusion of apoE4mut1-containing proteoliposomes in apoE-/- mice fed western-type diet for 6 weeks indicated that exogenously synthesized apoE4mut1 maintains intact its ability to normalize the high cholesterol levels of these mice with a maximum pharmacological effect obtained at only 10 hours post-treatment. Interestingly, plasma cholesterol levels remained significantly reduced even 24 hours following intravenous infusion of apoE4mut1 proteoliposomes. Measurements of plasma apoE levels indicated that apoE4mut1 in the form of proteoliposomes used in the study has a half-life of 15.8 h. Our data suggest that purified apoE4mut1 may be an attractive new candidate for the acute correction of hypercholesterolemia in subjects expressing functional LDL receptor.

No description available.

No description available.

Made available in DSpace on 2014-06-11T19:28:23Z (GMT). No. of bitstreams: 0 Previous issue date: 2010-02-24Bitstream added on 2014-06-13T18:57:29Z : No. of bitstreams: 1 souza_fa_me_jabo.pdf: 1931388 bytes, checksum: 4c66f4cd56386572eb7ad4b52f5d1472 (MD5) / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / Este trabalho avaliou a influência da heterocedasticidade e dos níveis nutricionais (número e posição) utilizados em ensaios dose-resposta, na estimativa do nível-ótimo e no ajuste dos modelos, além de verificar o quão informativas são as estatísticas utilizadas para avaliar a precisão do ajuste (R², R² ajustado, CV e SQD). Utilizaram-se dados dos experimentos realizados por Nascimento et al. (2007) e Siqueira (2009) e dados simulados. Constatou-se que, quando os níveis estiveram distribuídos próximos do verdadeiro requerimento, os modelos com platô proporcionaram resultados mais confiáveis. Já os modelos quadrático e exponencial se mostraram mais adequados para situações no qual os níveis estão mais dispersos em relação ao verdadeiro requerimento. A heterocedasticidade não interferiu na estimativa do nível-ótimo, porém influenciou no ajuste dos modelos e proporcionou pequenas mudanças nos parâmetros das equações obtidas. O coeficiente de determinação (ajustado e não ajustado) foi diretamente influenciado pela definição do nível mais próximo do ótimo e dos níveis extremos, enquanto que, o coeficiente de variação e a soma dos quadrados dos desvios, pelos níveis iniciais e pelo nível próximo do ótimo. A soma dos quadrados dos desvios demonstrou ser mais sensível, pois seu valor apresentou pequenas variações entre os modelos nas diferentes situações, que as outras estatísticas não detectaram. Ressalta-se a importância de se estabelecer corretamente o intervalo dos níveis estudados para que a dispersão dos valores do nível-ótimo estimado seja minimizada e que o ajuste seja satisfatório, independente do modelo utilizado / This work evaluated the influence of heteroskedasticity and the nutritional levels (number and position) used in dose-response trials to estimating the optimal-level and the adjustment of the models, also check how informative are the statistics used to evaluate the accuracy of fit (R ², R ² adjusted, CV and SQD). The data used in this experiment are from Nascimento et al. (2007) and’ Siqueira (2009) trials and simulated data. It was found that when levels were distributed close to the real requirement, the models with plateau have provided more reliable results. Since the quadratic and exponential models were more suitable for situations in which the levels are more dispersed about the real requirement. The heteroskedasticity did not affect the estimate of the level-optimal, but influenced the adjustment of the models and provided small changes in the parameters of the equations obtained. The coefficient of determination (adjusted and unadjusted) was directly influenced by the definition of the level closest to the optimum and extreme levels, while the coefficient of variation and the sum of squares of deviations were influenced by the initial levels and the level close to the optimum. The sum of squares of deviations was more sensitive, because its value showed small variations between models in different situations that the other statistics did not detect. Emphasized the importance to precisely define the range of levels studied to the dispersion of the obtained optimal-level is minimized and the fit is satisfactory regardless of the model

No description available.